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Abstract
Objective To assess the relationship between proximal femo-
ral cortical bone thickness and radiological hip osteoarthritis
using quantitative 3D analysis of clinical computed tomogra-
phy (CT) data.
Methods Image analysis was performed on clinical CT
imaging data from 203 female volunteers with a technique
called cortical bone mapping (CBM). Colour thickness
maps were created for each proximal femur. Statistical
parametric mapping was performed to identify statistically sig-
nificant differences in cortical bone thickness that corresponded
with the severity of radiological hip osteoarthritis. Kellgren and
Lawrence (K&L) grade, minimum joint space width (JSW) and
a novel CT-based osteophyte score were also blindly assessed
from the CT data.
Results For each increase in K&L grade, cortical thickness
increased by up to 25 % in distinct areas of the superolateral
femoral head–neck junction and superior subchondral bone
plate. For increasing severity of CT osteophytes, the increase
in cortical thickness was more circumferential, involving a
wider portion of the head–neck junction, with up to a 7 %
increase in cortical thickness per increment in score. Results
were not significant for minimum JSW.
Conclusions These findings indicate that quantitative 3D
analysis of the proximal femur can identify changes in cortical
bone thickness relevant to structural hip osteoarthritis.
Key Points
• CT is being increasingly used to assess bony involvement in
osteoarthritis
• CBM provides accurate and reliable quantitative analysis of
cortical bone thickness
• Cortical bone is thicker at the superior femoral head–neck
with worse osteoarthritis
• Regions of increased thickness co-locate with impingement
and osteophyte formation
• Quantitative 3D bone analysis could enable clinical disease
prediction and therapy development
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CBM Cortical bone mapping
CT Computed tomography
DRR Digitally reconstructed radiographs
JSW Joint space width
K&L Kellgren and Lawrence
MRI Magnetic resonance imaging
ROI Region of interest
SPM Statistical parametric mapping
Electronic supplementary material The online version of this article
(doi:10.1007/s00330-015-4048-x) contains supplementary material,
which is available to authorized users.
* Tom D. Turmezei
tdt21@cam.ac.uk
1 Department of Engineering, University of Cambridge,
Trumpington Street, Cambridge CB2 1PZ, UK
2 Department of Radiology, Addenbrooke’s Hospital,
Cambridge Biomedical Campus, Hills Road, Box 218,
Cambridge CB2 0QQ, UK
3 Department of Radiology, Royal National Orthopaedic Hospital,
Brockley Hill, Stanmore, Middlesex HA7 4LP, UK
4 Department of Medicine, Addenbrooke’s Hospital,
Cambridge Biomedical Campus, Hills Road, Box 157,
Cambridge CB2 0QQ, UK
Eur Radiol
DOI 10.1007/s00330-015-4048-x
Introduction
Hip osteoarthritis is an enormous health burden estimated
to affect one in four individuals in the USA during their
lifetime [1]. Frustratingly there are no disease-modifying
therapies currently approved for the treatment of any form
of osteoarthritis, with substantial breakthroughs in therapy
development hampered by an ongoing need for reliable
biomarkers [2, 3].
Clinical and epidemiological studies continue to define
disease with radiographic Kellgren and Lawrence (K&L)
grading [4], but this system has been shown to suffer
from variable interpretation [5]. The current recommended
definition of disease progression for clinical trials is change
in radiographic minimum joint space width (JSW) [6].
However, relevant progression needs to be defined within
each study, which can complicate comparisons between
different populations, while techniques of JSW measure-
ment have been reported to have poor reproducibility [7,
8]. Radiographic assessment is also limited by 2D inter-
pretation of a 3D structure.
Magnetic resonance imaging (MRI) stands at the fore
of imaging in osteoarthritis research, but despite prom-
ise from a variety of structural and biochemical tech-
niques, quantitative MRI has not yet delivered a sub-
stantiated osteoarthritis biomarker. However, clinical
computed tomography (CT) has gained momentum in
imaging of osteoarthritis in recent years [8–10]. This
is because bone has become increasingly apparent as a
key player alongside cartilage and synovium. It is also
apt as a modality given the proposed structural mecha-
nisms of femoro-acetabular impingement [11]. Although
not yet approved for clinical use in humans, there have
been encouraging reports on the efficacy of a bone-
related agent, strontium ranelate, from one clinical trial
[12], providing motivation to monitor mineralised tissues.
Quantitative CT of bone is further supported by recent
opinion that careful alignment of therapeutic action, tissue
response and imaging should yield the greatest chance of
detecting longitudinal change with the required sensitivity
[13].
In line with these strategies, our primary aim was to
assess the relationship between cortical bone thickness and
radiological hip osteoarthritis with a view to developing a
new method for disease quantification. We propose this
through the application of a recognised 3D image analysis
technique called cortical bone mapping (CBM) [14–16].
Our hypothesis was that CBM would be able to identify
regions of cortical bone thickening around the proximal
femur associated with worse radiological osteoarthritis,
predicting this would be in the distribution of recognised
peri-articular bone-related phenomena such as osteophytes
and subchondral sclerosis.
Material and methods
Participants
Participants for this observational study were taken from a
cohort of 204 female control volunteers involved in existing
Cambridge trials investigating hip fracture risk (57 from
FEMCO: LREC 07-H0305-61; 38 from MRC-Hip fx and
100 from MRC-Ageing: LREC 06/Q0108/180; 9 from
MRC-Stroke: LREC 01/245). The local research ethics com-
mittee approved each of these studies, with each participant
giving informed consent for the analysis of their CT data for
the investigation of hip disease. All participants were free of
hip fracture, osteomyelitis, bone malignancy, unilateral meta-
bolic bone disease, terminal illness and prior treatment with
teriparatide or strontium ranelate. All examinations were re-
ported by a consultant radiologist as part of the routine clinical
care of patients. One of the 204 examinations was unavailable
for analysis on account of data corruption and so imaging was
used from 203 individuals. The mean [± standard deviation
(SD)] age of this final group was 65±18 years; mean weight
was 70.1±14.4 kg; mean height was 1.62±0.07m;mean body
mass index (BMI) was 26.9±5.4 kg/m2. No height data was
available for one individual and so she was given the sample
mean value.
Imaging acquisition
Imaging of the hips was acquired helically in the supine posi-
tion on five different clinical whole-body multi-detector CT
machines (Siemens SOMATOM Sensation 16, Sensation 64,
Definition Flash, Definition AS+, and a GE Medical Systems
Discovery 690). The acquisition protocol involved imaging
inclusively from the superior margin of the acetabuli to the
lesser trochanters. All acquisitions were processed with a stan-
dard smooth-edge body kernel and reconstructed with axial
slice separation ranging from 0.75 to 1.5 mm, equivalent to
slice thickness in all cases. In-plane pixel spacing varied from
0.59 to 0.78 mm, with field of view consistently 512 by
512 pixels. Peak kV was routinely 120 kV. When available
from the fully anonymised metadata, recorded exposure
ranged from 67-274 mAs, varying due to routine use of dose
limiting.
Radiological measures of hip osteoarthritis
Since there were no clinical measures of disease available
in this cohort, we used radiological scores to grade disease
severity. Digitally reconstructed radiographs (DRRs) were
created using an anatomically standardised coronal mean
intensity projection with a window level of 200 Hounsfield
units (HU) and a width of 700 HU. DRRs were reviewed
by a consultant radiologist (AF) for K&L grading (0 to 4)
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[4] and minimum JSW, recorded to the nearest 0.1 mm with
electronic callipers. Multi-planar reformats were reviewed by
another consultant radiologist (TT) for osteophyte load, a
reviewer-generated cumulative score of osteophytes graded
from 0 to 3 in 42 separate sectors from around the proximal
femur [10]. The maximum score in this cohort was 47, and so
this was the upper limit used in our analysis. Full details of
DRR and scoring methodologies (including reliability) have
been previously published [8, 10].
We investigated the effect of these radiological measures
on cortical thickness in the proximal femur, with the assumption
of a linear relationship with disease for each. Frequency histo-
grams were created for each radiological score usingMATLAB
2013a (© 1984-2013, TheMathsWork, Inc.) to demonstrate the
spread of disease severity (Fig. 1). The assumption of linearity
was validated by scatter plots and calculation of Kendall’s tau
correlation coefficient using StatPlus®:mac 2009 (AnalystSoft,
StatPlus:mac - statistical analysis program for Mac OS. Version
2009; http://www.analystsoft.com/en/). Each covariate showed
a linear relationship and significant correlation with the other
(Electronic SupplementaryMaterial 1).When both femurs were
available, the side with the worse disease score was selected
for analysis in order to minimise the risk of including only
those with no or minimal disease. If disease scores were
equal, then a sidewas chosen randomly for inclusion. Repeating
analyses with different randomisation did not affect the pattern
or significance of our results.
Cortical thickness measurement
Cortical thickness measurement was performed using CBM,
implemented by a freely available in-house program called
Stradwin (http://mi.eng.cam.ac.uk/~rwp/stradwin/). The
main strength of this technique is its ability to accurately
estimate cortical bone thickness below the pixel spacing of
the imaging system, irrespective of partial volume effect. It
has been validated for clinical CT against high resolution
quantitative CT data acquired at 82 microns per pixel, and
applied in clinical CT data sets up to a slice separation of
3 mm [14, 17, 18]. Following semi-automatic segmentation
and proximal femur mesh generation, cortical thickness was
measured at each of ~6,000-mesh vertices at a normal to the
underlying cortical surface. Creation of a single 3D thickness
map takes, on average, 15 minutes; the majority of this time is
spent on semi-automatic segmentation, which varies accord-
ing to noise in the data, while automatic thickness analysis
usually takes under 1 minute on a standard desktop computer.
Measurement error (± SD) at any given point has been previ-
ously reported as 0.12±0.39mm, well below the pixel spacing
size in this study and otherwise in daily clinical practice [18].
Precision has also been assessed in repeat analysis of 19 indi-
viduals re-imaged with CTand re-analysed after an average of
61 days (SD 22 days, range 34 to 107 days) giving a measure-
ment precision of 5 % of the mean at individual points,
dropping to 1 % of the mean when measurements were aver-
aged over a defined region of interest (ROI) [19].
In order to account for differences in hip morphology,
each proximal femur was spatially re-aligned with a canonical
right femur using B-spline free-form deformation as calculated
by an iterative closest-point registration algorithm [20]. This was
performed using freely available in-house software called
WxRegSurf (http://mi.eng.cam.ac.uk/~ahg/wxRegSurf/).
Spatially normalised cortical thickness maps were then
smoothed with a 10-mm full width at half maximum (FWHM)
filter, required for statistical parametric mapping (SPM). After
registration of each bone to the canonical femur, SPM was per-
formed to determine regions of significantly different cortical
thickness for changes in radiological disease score.
Statistical parametric mapping (SPM)
SPMwas initially developed for applications in neuroimaging
to allow regionally located statistical inferences to be made
from the comparison of data at multiple points in space. It uses
a general linear model to account for variability in measure-
ment data (here, cortical thickness) in terms of experimental
Fig. 1 Frequency histograms for each of the radiological scores. a Kellgren and Lawrence (K&L) grade; b osteophyte load; and c minimum
JSW at 0.1-mm gradations
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and confounding effects. Effects in our general linear model
were radiological disease score (experimental), age and
weight (confounding, as revealed by preliminary analysis).
Standard two-tail F testing across the cohort gave p-values at
each measurement location that were uncorrected for multiple
comparisons. As required for SPM, random field theory de-
livered p-values corrected for these multiple comparisons to
control for false positive results (type I errors) [21]. SPM was
performed using the SurfStat package [22] in MATLAB
2013a (© 1984-2013, The MathsWork, Inc.). A mean thick-
ness map was also produced for the whole cohort (Fig. 2),
allowing change in cortical thickness to be represented as a
percentage of the mean. Therefore, three sets of results were
calculated for each disease score:
(a) Absolute cortical thickening (in mm) for each unit wors-
ening in radiological measure;
(b) Relative cortical thickening (as a percentage of the mean
value) for each unit worsening in radiological measure;
and
(c) Subsequent regions of significant differences in cortical
bone thickness across the cohort.
Significant regions of cortical bone thickness difference
are Bclusters^ that meet statistical significance when tested
after random field theory correction. For the purposes of
visualising results effectively, all non-significant regions
were indicated by washed out colour over the relative
thickness maps (Figs. 3, 4, and 5). Absolute cortical thickness
maps are included in the Electronic Supplementary Material
(2 to 4) for reference against these relative thickness maps. An
overview of the CBMpathway from data acquisition to results
is presented as a flowchart in Fig. 6.
Results
Cortical bone mapping results for three radiological measures
of disease (K&L grade, osteophyte load and minimum JSW)
are shown as a colour map on a canonical model in Figs. 3, 4,
and 5, with non-significant regions according to SPM indicated
by faded colours. Therefore, significant regions of cortical bone
thickness difference with worsening disease score (p<0.05)
are represented in full colour in contrast to faded regions of
non-significance.
Kellgren and Lawrence (K&L) grade
There was up to 25 % significantly thicker cortical bone for
each unit increase in K&L grade at the superolateral and an-
terior femoral head-neck junction, with extension into the su-
perior subchondral bone plate (Fig. 3). The map for absolute
differences in cortical thickness is presented in Electronic
Supplementary Material 2, showing that 25 % was equivalent
to a 0.1 mm increase per each unit increase in grade (0 to 4).
Osteophyte load
There was up to 7 % significantly thicker cortical bone for
each unit increase in osteophyte load score circumferentially
around the head–neck junction, extending medially across the
superior subchondral bone plate to the fovea, and laterally into
the posterior and medial femoral neck (Fig. 4). The map for
absolute differences in cortical thickness is presented in Elec-
tronic SupplementaryMaterial 3, showing that 7%was equiv-
alent to a 0.02 mm increase per each unit increase in osteo-
phyte load (0 to 47 in this cohort).
Minimum joint space width (JSW)
There was no significant difference in cortical bone thickness
for each mm decrease in minimum JSW (Fig. 5), although
cortical thickness at the superolateral head-neck junction still
increased by up to 20 % for each mm decrease in minimum
JSW. Themap for absolute differences in cortical thickness for
minimum JSW is presented in Electronic Supplementary
Material 4, showing that 20 % was equivalent to a 0.08 mm
increase per each mm decrease in minimum JSW.
Discussion
We have applied a quantitative 3D image analysis technique to
clinical CT imaging data to identify significant cortical bone
Fig. 2 Mean cortical thickness of the proximal femur. Mean cortical thickness map of the proximal femur from the 203 individuals in the study cohort,
presented as a colour wash on a canonical model of the right femur viewed from three perspectives: (left to right) anterior, superior and posterior
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thickening in association with worse radiological disease.
More specifically, this effect was localized to a defined
region at the femoral head–neck junction. Participants
had statistically significant (10–25 %) thickening of bone
at the superior and anterior aspects of this junction for
each unit increase in K&L grade, with significant effects
more widely distributed for osteophyte load. Although not
significant for minimum JSW, a relative increase in cortical
bone thickness at the same site across all scores suggests that
this region may be involved in a particular manifestation of
disease (as demonstrated by the red regions consistent in
Figs. 3, 4, and 5). Alternatively, minimum JSWmay be related
to an independent factor that we did not include in our
model. Three distinct bone phases have been recognised in
osteoarthritis: (i) initial osteoclastic subchondral bone re-
sorption; (ii) osteoblastic bone formation progressing to
sclerosis; then (iii) osteophyte formation at the articular
margin [23]. Our results suggest that CBM has picked
up the latter two of these effects.
In order to understand the implications of these results, it is
important to consider what CBM is registering as cortical
bone thickening. Our distribution of cortical involvement fits
with current biomechanical hypotheses of impingement at the
hip, covering regions of predicted increased contact pressures
at the superior and superolateral femoral head [24]. Another
study of individuals with cam impingement showed that max-
imal shear stresses on squatting were located in the supero-
anterior acetabulum, immediately opposite the site where we
have demonstrated thickened bone (Figs. 3 and 4) [25]. The
same study also localised stress maxima within subchondral
bone, supporting the notion that superolateral impingement is
influencing structural change here. It is, therefore, possible
that we are detecting a subclinical response in cortical bone
to mechanical effects of impingement at the superolateral
head–neck junction. CBM may also be detecting a cortical
manifestation of osteophyte growth. Figure 7 shows that this
may not necessarily be an osteophyte component outside the
cortex, since our algorithm selects the innermost of two layers
as the true cortex for analysis. Importantly, peri-articular cor-
tical bone and subchondral bone plate can appear thickened as
separate from osteophytes, or even in their absence, as review
of the underlying imaging data reveals (Fig. 7).
Before considering the next phase of validation for assess-
ment of osteoarthritis with CBM, it is important to evaluate
the implications of using clinical CT for this purpose. CT is
important for imaging joints and bone because it excels at
depictingmineralised structures in contrast to surrounding soft
tissue. In addition to providing a framework for finite element
studies [24–26], CT has also shown strength in representing
bone shape and early bone-related changes of disease at the
hip [27, 28]. The promotion of CT for imaging large joint
osteoarthritis should, therefore, be balanced against its
weaknesses and the inherent values of other modalities
such as MRI and radiography. This is of particular impor-
tance given the exposure to ionising radiation that it entails
along with the proximity of radiation-sensitive tissues in the
pelvis (which is, therefore, relatively less dose at more distal
joints such as the knee). However the continual development
Fig. 3 Cortical bone mapping (CBM) results for Kellgren and Lawrence
(K&L) grade. CBM results for K&L grade presented as a colour wash on
the canonical right proximal femur. Significant regions of cortical bone
thickness difference for each unit increase in K&L grade (0 to 4) are
represented by the colour map (p<0.05), with non-significant regions
indicated by faded colours (p>0.05)
Fig. 4 Cortical bone mapping (CBM) results for osteophyte load. CBM
results for osteophyte load presented as a colour wash on the canonical
right proximal femur. Significant regions of cortical bone thickness
difference for each unit increase in osteophyte load score are represented
by the colour map (p<0.05), with non-significant regions indicated by
faded colours (p>0.05)
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of dose reduction strategies should encourage consideration
for CT in clinical trials [29, 30].
We recognise that this study has limitations. Our assess-
ment of hip osteoarthritis severity was based on imaging
features alone, which do not necessarily correlate with clinical
osteoarthritis. Thus, the next step would be to test the hypoth-
esis that increased peri-articular cortical bone thickness can
predict worse disease according to clinical outcome measures.
We also recognise that individuals from this cohort were pre-
selected on the basis of volunteering for studies in which the
aim was to establish hip fracture risk, and so there will be
according selection bias. Finally, subchondral bone sclerosis
is a recognised radiological feature used in assessment with
K&L grading, meaning that there will be some dependence of
the output of our cortical thickness analysis on K&L grade,
since DRRs were created from the same CT data. Nonethe-
less, we believe that CBM should now be tested to show
whether quantitative 3D measurement of cortical bone with
clinical CT can predict clinical disease with the necessary
levels of sensitivity and precision [31]. The role of CBM in
the prediction of osteoarthritis at other large joints, such as the
knee, should also be evaluated.
Fig. 5 Cortical bone mapping (CBM) results for minimum joint space width (JSW). CBM results for minimum JSW presented as a colour wash on the
canonical right proximal femur. All colours were faded for this variable, meaning that there were no regions of significance (p>0.05)
Fig. 6 Cortical bone mapping (CBM) flowchart. Each stage of the CBM
pathway is represented to summarise the study methodology. SPM =
statistical parametric mapping
Fig. 7 Cortical thickness at the superolateral femoral head-neck junction.
Axial CT images of the right hip in two individuals from the cohort
viewed in Stradwin, the software used to perform CBM. Dotted green
lines represent the approximate contour for the femoral isosurface. Cyan
lines represent the path of thickness measurement. Red dots represent the
estimated limits of cortical bone, neither of which need be coincident with
the original green contour. Individual (a) had a Kellgren and Lawrence
(K&L) grade of 1, an osteophyte load of 4 (out of a maximum of 126),
and a minimum JSW of 2.0 mm. Note that the measurement line is at a
site with apparently greater cortical thickness than surrounding bone yet
in the absence of an osteophyte. Individual (b) had a K&L grade of 3, an
osteophyte load of 44 (out of 126), and a minimum JSWof 1.2 mm. Note
that the measurement line in (b) has picked up two layers of bone, the
underlying cortex and the osteophyte outside it. Note that there is also
apparent increased cortical bone thickness in the anterior femoral head
anteromedially and separate to the osteophyte (arrowhead)
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Conclusion
CBM applied to the proximal femur in clinical CT imaging
data identified significant structural changes in peri-articular
cortical bone thickness that were associated with worse radio-
logical hip osteoarthritis, particularly at the superolateral
head–neck junction. These findings are best explained by
the manifestation of osteophytes and subchondral sclerosis
in this region, which may be either in response to local bio-
mechanical stresses or the biochemical environment as the
joint fails. CBM could, therefore, have an impact on both
osteoarthritis research and subsequent clinical practice, espe-
cially with potential for application in disease monitoring and
the development of structurally modifying therapies.
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